Antonio “Tito”Fojo, M.D. Ph.D. is Professor in the Division of Hemotology and Oncology at Columbia University Medical Center. He received his M.D. and Ph.D.from the University of Miami and completed internal medicine training at Washington University School of Medicine / Barnes Hospital. Prior to his arrival at Columbia Dr. Fojo was a Principal Investigator in the Medicine Branch, and Program Director for the Medical Oncology Fellowship Program, of the National Cancer Institute, where he established a highly successful translational clinical program. Dr. Fojo works to understand the molecular basis of drug resistance, and has worked on the development of novel microtubule-targeting agents therapies for endocrine and neuroendocrine cancers, Dr. Fojo is also active in the design, conduct and interpretation of oncology clinical trials.
Beverly A. Teicher, PhD is Chief of the Molecular Pharmacology Branch at the National Cancer Institute (NCI), Dr. Teicher completed a PhD in Bioorganic Chemistry at the Johns Hopkins University and postdoctoral training at Yale University School of Medicine. After positions at the Dana-Farber Cancer Institute and Harvard Medical School, Dr. Teicher served as Research Advisor in Cancer Drug Discovery at Lilly Research Laboratories and Vice President of Oncology Research at Genzyme. Dr. Teicher is best known for her work in solid tumor models and physiologic measurements of tumor hypoxia and oxygenation. She has authored or co-authored more than 400 scientific publications, edited eight books, and is editor for the journal Clinical Cancer Research, the journal Pharmacology and Therapeutics, and the Cancer Drug Discovery & Development book series.
Michael A. White, Ph.D. is Professor of Cell Biology and the Grant A. Dove Chair for Research in Oncology at the University of Texas Southwestern Medical Center. His research is aimed at uncovering the molecular nature of cell autonomous regulatory mechanisms with the goal of permitting appropriate responses of human cells to their environment. Dr. White received his undergraduate degree from the University of Iowa, and a Ph.D. from the University of North Carolina. Through elaboration of the biogenesis of catabolic organelles, Dr. White’s laboratory is helping to uncover some of the central principles that govern cellular homeostasis, and examining the processes governing the adaptive modulation of cell growth and self-renewal. His ultimate goal is to identify authentic intervention targets for the development of a sufficiently diverse cohort of therapies to contend with oncological heterogeneity.